Skip to content

Drug interactions

Anagrelide + Selumetinib

Severity: Moderate

Anagrelide and Selumetinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Anagrelide inhibits platelet aggregation, and selumetinib carries a bleeding risk and contains vitamin E that may add to antiplatelet effects. Combined use may increase the risk of bleeding.

What this interaction means in plain words

Anagrelide and Selumetinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Anagrelide belongs to Cardiovascular; Selumetinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive antiplatelet effect of anagrelide with the bleeding tendency of selumetinib and its vitamin E content.

What to do

Monitor for bruising and bleeding and check platelet counts and coagulation parameters if on other antithrombotics. Avoid additional antiplatelet or anticoagulant drugs where possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Anagrelide and Selumetinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Anagrelide with Selumetinib?

MediHelp rates the interaction as moderate. Anagrelide and Selumetinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Anagrelide inhibits platelet aggregation, and selumetinib carries a bleeding risk and contains vitamin E that may add to antiplatelet effects. Combined use may increase the risk of bleeding.

How serious is the interaction between Anagrelide and Selumetinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bruising and bleeding and check platelet counts and coagulation parameters if on other antithrombotics. Avoid additional antiplatelet or anticoagulant drugs where possible.

What other medicines interact with Anagrelide?

MediHelp also lists interactions of Anagrelide with, for example, Panobinostat, Pimozide, Thioridazine. The full list is on the Anagrelide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in